image

All viewers must Log In in order to register for a webinar.

In order to register for an on-demand webinar, select the "Log In" button on the right side of the page and use your IPO username and password.  If you do not remember your log in credentials, you will be prompted to reset your password or create a new account. For questions about how to log in, email meetings@ipo.org

Note: Webinar audio is streamed through your computer. Be sure to have your speakers turned on and volume up when tuned in to a webinar.

On-Demand Webinars

Search by Category
Search by Type
Sort By
  • On May 21, 2024, the Federal Circuit sitting en banc issued its opinion in LKQ v. GM, striking down the forty-plus year-old Rosen-Durling test for design patent obviousness, and announcing a new framework based on Graham v. John Deere. This webinar will explore where stakeholders go from here. The discussion will include a comparison of how the Graham analysis has affected utility patent determinations of obviousness, and what this could mean for design patent applications during prosecution. Panelists will also consider how the new framework may affect design patent litigation, including claim construction, discovery, summary judgment, and trial. Finally, speakers will consider whether a new system for protecting designs could offer an alternative to the uncertainties created by the LKQ decision.

  • This panel will discuss issues for in-house counsel to consider in guiding business teams interested in leveraging new generative AI tools. Attendees will leave with a checklist for establishing a considered approach to using AI within their company.

  • In this session, speakers will provide an update on various harmonization areas, such as global assignment, e-signatures, and artificial intelligence (AI). Global assignment relates to the creation of a recordable IP assignment form, along with the institution of a central depository where the form could be filed and recognized by multiple jurisdictions. E-signature efforts explore legal pathways for the IP Offices to broadly accept use of electronic signatures by applicants provided that certain minimum requirements are met. Finally, AI harmonization efforts aspire towards common treatment of AI-related inventions and are furthermore directed to using AI to facilitate the patent grant process.

  • The panel will focus on various ethical concerns and obligations of which counsel should be aware when using AI tools, such as confidentiality, competence, candor, supervision, and bias. The panel will also focus on applicable ethical regulations pertaining to using AI tools in the IP space, including the positions of practice before the USPTO and district courts.

  • This webinar will explore best practices for thinking about sufficiency of disclosure when pursuing patent protection for AI inventions. Panelists will talk through the technology and legal framework, including recent decisions from the European Patent Office and U.S. Patent and Trademark Office, and provide practical approaches to addressing this area when drafting patent applications.

  • This session will discuss transfer pricing best practices, including organization structures, valuations and the agreements that need to be put in place to help IP professionals support their organizations’ transfer pricing teams.

  • During this webinar, panelists will discuss how to leverage your IP rights to assist in stopping illicit trade.

  • This webinar will explore various issues around the current hot topic of different work models and their impact on lawyers, law firms, and in-house legal departments. In particular, this webinar will include a robust discussion around the mental health impact on lawyers; the DEI impact on lawyers, law firms, and in-house legal departments; and the various pros and cons of lawyers working remotely, in a hybrid model, or 100% in-office. *CLE Note* VA has approved this course for 0.5 Well-Being credit & IL has approved this course for 0.25 Diversity & Inclusion Credit and 0.25 Mental Health and Substance Abuse credit.

  • This webinar will feature a panel of who’s who of PTAB judges who will address many issues involving AIA proceedings. Whether you represent patent owners or petitioners you will want to attend the program. The judges will address the perceived success rates of petitioners, motions to amend, serial and parallel proceedings, use of secondary considerations evidence, proper use of expert testimony, Sotera stipulations, real parties in interest, discovery requests, Director review and more. The panel will also provide an update on proposed rule changes as well as dos and don’ts of brief writing and oral argument. *PLEASE NOTE that This webinar does not qualify for CLE.*

  • This webinar will provide a recap of many of the key trademark cases from the Trademark Trial and Appeal Board and the Federal Circuit in 2023, highlighting decisions regarding failure to function as a trademark, use in commerce, standing, and more.

  • This webinar will address major relevant developments in generative artificial intelligence, such as ChatGPT, as related to patent prosecution. The panel will discuss some recent takeaways from case law, developments in AI tools, and practice tips for attorneys looking to begin implementing AI tools in their everyday work. In particular, the panel will continue a discussion started at the IPO Annual Meeting regarding the proper role of generative AI in prosecution, as opposed to “classic” AI approaches or human drafting.

  • This webinar will explore the evolving landscape of pharmaceutical patents, focusing on key issues facing the industry. Topics include emerging jurisprudence concerning induced infringement based on prescribing information, and challenges and strategies related to validity, including written description, enablement, and obviousness. Additionally, speakers will examine the latest USPTO guidance concerning the intersection of inventorship and AI, and delve into issues impacting patent term, in particular double patenting and continuation practice. Finally, panelists will provide an update on issues to be aware of concerning listing patents in FDA’s Orange Book.

  • On February 5, an en banc Federal Circuit will consider whether the current design patent obviousness test is overly rigid and should be revised. The Court has issued a series of detailed questions to be considered and this forthcoming decision could fundamentally change the issue of design patent obviousness as well as the perceived value of design patent protection. In preparation for the argument, this webinar will discuss an overview of the issues to be considered, a detailed dive into the United States’ brief and the amicus brief from Apple (both of which are expected to be important to the Court), and consideration of how this decision could affect the design patent obviousness question at the PTAB and the district court level in the future. The panel will also discuss details about what to expect during the oral argument. After the webinar, audience members will be armed with the knowledge they need to get the most out of the upcoming oral argument.

  • During this webinar, panelists will discuss the guidelines and potential consequences of the proposal. Under Bayh-Dole, universities and other contracting organizations are given rights to intellectual property generated from federally funded research and enabled to license these inventions to private sector partners who can then commercialize them. It includes a “march-in” provision that permits the government, in specific and limited circumstances, to require the patent holder to grant additional licenses to the patented technology.

  • A panel of highly experienced patent attorneys from the US, Europe and Japan will discuss recent court decisions on patent enablement, the impact for future decisions, and strategies for addressing enablement in patent applications and litigation. They will provide a brief overview of patent enablement in each country and discuss recent decisions including the US Supreme Court decision in Amgen and the Amgen cases in Europe and Japan. In addition, they will compare and contrast the patent enablement requirements for each country and provide strategies for complying with enablement.